JPRN-UMIN000042478Recruiting未知
Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes. - Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes.
Saiseikai Yokohamashi Nanbu Hospital0 sites80 target enrollmentStarted: November 18, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Patients with severe liver dysfunction 2) Patients with severe renal dysfunction(eGFR<30ml/min/1.73) 3) Patients with fasting serum CPR <0.5 or postprandial serum CPR <1.0 4) Patinet with diabetic ketoacidosis 5) Patient with infection 6) Patients taking steroid 7) Patients with malignant tumor currently undergoing treatment 8) Pregnant or lactating woman 9) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor
Investigators
Similar Trials
Completed
Not Applicable
Study on association between beta cell function and glycemic variability in the non-diabetic subjects with normal glucose tolerance and impaired glucose tolerancediabetesJPRN-UMIN000020002Kobe University Graduate School of Medicine100
Not yet recruiting
Not Applicable
A retrospective study on beta cell function in type 2 diabetic patients using GLP-1 receptor agonistType 2 diabetes mellitusJPRN-UMIN000031697Showa University of medicine, the department of internal medicine, the division of diabetology, metabolism and endocrinology60
Completed
Not Applicable
Evaluation of functional beta cell mass with the use of Glucagon stimulation testImpaired glucose tolerance and Type 2 diabetesJPRN-UMIN000015973Division of Endocrinology and Diabetes, Iwaki Kyoritsu General Hospital300
Completed
Not Applicable
Islets beta-cell function and usefulness of sulfonylureas in glycemic control in type 2 diabetic patients with sulfonylurea failure.oneSulfonylurea failureType 2 DMTCTR20170525001one25
Withdrawn
Not Applicable
Characterization of Beta Cell FailureMetabolic SyndromeDiabetesNCT00869102University Hospital Tuebingen